Key facts
- Notable investors include Innovation Authority, Entrée Capital, Hadassah Accelerator, IN Venture, Road2 Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for LiteBC
- ·The full record, as it builds
Funding rounds
No funding rounds for LiteBC are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LiteBC
Developer of a noninvasive blood count device intended for real-time monitoring of blood cells in vivo. The company's device allows users to place the handheld optical probe on the patient's lip and analyze vital blood count parameters, enabling users to perform blood testing anywhere and anytime with continuous health data to support preventative and personalized medicine.
- Sector
- Healthcare
- HQ
- Yokeam Illit, Israel
- Founded
- 2019
- Employees
- 17
- Website
- litebc.tech/
- Ownership
- Privately Held (backing)
LiteBC doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LiteBC shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LiteBC in its N-PORT filings yet. We sweep new filings monthly.